Finally, KDR, which we won't talk about as I'm still yet to see a suitable entry from the lows of $0.35 and with it now +40% makes me sad.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025